Delivering tomorrow’s immunotherapies to cancer patients today
Roswell Park is among 28 elite universities and cancer centers in North America that make up the Cancer Immunotherapy Trials Network (CITN). The goal: to help top immunologists speed access to the most promising cancer immunotherapies through clinical trials. The CITN works in conjunction with the National Cancer Institute, philanthropic institutions, and industry partners.
Are You Eligible?
Patients eligible through clinical trials may have access to cutting-edge vaccines that will boost the immune system’s response to cancer cells.
Still Unsure About a Clinical Trial?
Clinical trials are designed to evaluate promising new medical treatments. Learn why they might be your best option.